作者: B. Christensson , B. Tribukait , P. Biberfeld
DOI: 10.1007/978-1-4613-2607-6_11
关键词: Cancer research 、 Functional diversity 、 Biology 、 Non-Hodgkin's lymphoma 、 Kiel classification 、 Rappaport 、 Stepwise discriminant analysis 、 Mycosis fungoides 、 DNA 、 Immunology
摘要: The Rappaport classification is widely used for diagnosis and treatment of non-Hodgkin’s lymphomas (NHL) [1–3]. However, it has become increasingly inconsistent with the rapidly changing concepts functional diversity immune system. Attempts have, therefore, been made to incorporate immunologic into morphologic NHL [4, 5]. clinical applicability these newer classifications as well their capacity identify biologically distinct tumor groups currently under study.